The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1
Keywords: Chimeric peptide vaccine; MPLA; ISCOMATRIX; Cell-mediated immune response; Mucosal immunity; HTLV-1;